Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stoddart, A.
Right arrow Articles by Paige, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoddart, A.
Right arrow Articles by Paige, C. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 9, 1571-1579, Copyright © 1997 by Oxford University Press

ARTICLES

Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM

A Stoddart, RJ Ray and CJ Paige
Wellesley Hospital Research Institute, Wellesley Central Hospital, Toronto, Ontario, Canada.

CD22 is a B cell-restricted glycoprotein involved in cell adhesion and signaling. Since CD22 is likely to play an important role in interactions between B cells and other cells, and in regulating signaling thresholds, we characterized the expression of murine CD22 during different stages of B cell development. In contrast to previous reports, we show that CD22 is expressed on B cell progenitors prior to expression of IgM. IL-7-responsive B cell precursors from the fetal liver and early B lineage cells (B220+IgM-) from the bone marrow both express a low density of surface CD22. The majority of the earliest B cell progenitors (B220+IgM-CD43+) in the bone marrow, however, do not express CD22. As B cells mature, the density of CD22 molecules on the cell surface increases. B220brightIgM+ bone marrow cells express high levels of CD22, as do splenic B cells. The correlation of CD22 levels with B cell maturation is replicated in an in vitro culture system, which distinguishes stages of B cell development based on function. Following activation of mature resting splenic B cells with anti-mu mAb or lipopolysaccharide (LPS), levels of CD22 decrease. Finally, we show that the addition of anti-CD22 mAb augments the proliferative response of both anti-mu- and LPS-stimulated B cells, suggesting a role for CD22 in diverse signaling pathways.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
J. E. Crowley, J. E. Stadanlick, J. C. Cambier, and M. P. Cancro
Fc{gamma}RIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation
Blood, February 12, 2009; 113(7): 1464 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Grimaldi, R. Hicks, and B. Diamond
B Cell Selection and Susceptibility to Autoimmunity
J. Immunol., February 15, 2005; 174(4): 1775 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. E. Fleming, C. D. Milne, and C. J. Paige
CD45-Deficient Mice Accumulate Pro-B Cells Both In Vivo and In Vitro
J. Immunol., August 15, 2004; 173(4): 2542 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. Tretter, A. E. Ross, D. I. Dordai, and S. Desiderio
Mimicry of Pre-B Cell Receptor Signaling by Activation of the Tyrosine Kinase Blk
J. Exp. Med., December 15, 2003; 198(12): 1863 - 1873.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. C. Otero and R. C. Rickert
CD19 Function in Early and Late B Cell Development. II. CD19 Facilitates the Pro-B/Pre-B Transition
J. Immunol., December 1, 2003; 171(11): 5921 - 5930.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. A. Muljo and M. S. Schlissel
The variable, CH1, CH2 and CH3 domains of Ig heavy chain are dispensable for pre-BCR function in transgenic mice
Int. Immunol., June 1, 2002; 14(6): 577 - 584.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
S. A. Wuensch, R. Y. Huang, J. Ewing, X. Liang, and J. T. Y. Lau
Murine B cell differentiation is accompanied by programmed expression of multiple novel {beta}-galactoside {alpha}2,6-sialyltransferase mRNA forms
Glycobiology, January 1, 2000; 10(1): 67 - 75.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Yohannan, J. Wienands, K. M. Coggeshall, and L. B. Justement
Analysis of Tyrosine Phosphorylation-dependent Interactions between Stimulatory Effector Proteins and the B Cell Co-receptor CD22
J. Biol. Chem., June 25, 1999; 274(26): 18769 - 18776.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. L. O'Keefe, G. T. Williams, F. D. Batista, and M. S. Neuberger
Deficiency in CD22, a B Cell-specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies
J. Exp. Med., April 19, 1999; 189(8): 1307 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. S. Miller, V. McCullar, M. Punzel, I. R. Lemischka, and K. A. Moore
Single Adult Human CD34+/Lin-/CD38- Progenitors Give Rise to Natural Killer Cells, B-Lineage Cells, Dendritic Cells, and Myeloid Cells
Blood, January 1, 1999; 93(1): 96 - 106.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.